Picture of Wakamoto Pharmaceutical logo

4512 — Wakamoto Pharmaceutical News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareAdventurousMicro CapNeutral

Table: Wakamoto Pharm -6-MTH parent results

Nov 2 (Reuters)-  
             Wakamoto Pharmaceutical Co Ltd  
             PARENT-ONLY FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                 6 months ended      6 months ended       Year to  
                Sep 30, 2016        Sep 30, 2015     Mar 31, 2017  
                   LATEST             YEAR-AGO          LATEST     
                   RESULTS             RESULTS         FORECAST    
  Sales             5.49                5.50             11.20     
                 (-0.1 pct)          (+4.1 pct)       (+0.1 pct)   
  Operating      loss 59 mln           74 mln           60 mln     
                                    (+531.8 pct)      (-27.9 pct)  
  Recurring      loss 51 mln           103 mln          40 mln     
                                    (+272.0 pct)      (-68.0 pct)  
  Net            loss 33 mln           61 mln            2 mln     
                                    (+441.3 pct)      (-90.2 pct)  
  EPS           loss 0.97 yen         1.77 yen         0.06 yen    
  Ann Div                             3.00 yen                     
  -Q2 div            NIL                 NIL                       
  -Q4 div                             3.00 yen                     
   
  NOTE - Wakamoto Pharmaceutical Co Ltd.  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4512.T  
  ((Tokyo Headline News Desk +813 6441 1812))

Recent news on Wakamoto Pharmaceutical

See all news